The DOI matches its Crossref record; 211 of the 214 references it cites were found in a registry or an index, and 3 are not checked yet.
Behavioral and Psychological Symptoms of Dementia
Open accessAbstract
Behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms, represent a heterogeneous group of non-cognitive symptoms and behaviors occurring in subjects with dementia. BPSD constitute a major component of the dementia syndrome irrespective of its subtype. They are as clinically relevant as cognitive symptoms as they strongly correlate with the degree of functional and cognitive impairment. BPSD include agitation, aberrant motor behavior, anxiety, elation, irritability, depression, apathy, disinhibition, delusions, hallucinations, and sleep or appetite changes. It is estimated that BPSD affect up to 90% of all dementia subjects over the course of their illness, and is independently associated with poor outcomes, including distress among patients and caregivers, long-term hospitalization, misuse of medication, and increased health care costs. Although these symptoms can be present individually it is more common that various psychopathological features co-occur simultaneously in the same patient. Thus, categorization of BPSD in clusters taking into account their natural course, prognosis, and treatment response may be useful in the clinical practice. The pathogenesis of BPSD has not been clearly delineated but it is probably the result of a complex interplay of psychological, social, and biological factors. Recent studies have emphasized the role of neurochemical, neuropathological, and genetic factors underlying the clinical manifestations of BPSD. A high degree of clinical expertise is crucial to appropriately recognize and manage the neuropsychiatric symptoms in a patient with dementia. Combination of non-pharmacological and careful use of pharmacological interventions is the recommended therapeutic for managing BPSD. Given the modest efficacy of current strategies, there is an urgent need to identify novel pharmacological targets and develop new non-pharmacological approaches to improve the adverse outcomes associated with BPSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Abnormalities in neuropsychiatric states were common among the VEEV TC-83 inoculated WT and Tg2576 mice and were exaggerated responses to the normal, indicating anxiety-like behavior, irritability, or dementia, which are associated with the sequelae of alphaviruses (Reisberg et al., 1987) and with AD (Cerejeira et al., 2012).”
From Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model (2024) · cites this paper as Cerejeira et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders
(2012) · Springer eBooks · doi:10.1007/springerreference_121117 · Cited by 20,772
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationThe Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
The Neuropsychiatric Inventory
Cummings, J. L. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_6.10s · Cited by 2,055
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024
(1987) · PubMed · Cited by 1,147
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C., & Breitner, J. C. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.708 · Cited by 1,144
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
Research works printed but not linked: 4
- Aalten P. de Vugt M. E. Jaspers N. Jolles J. Verhey F. R. (2005b). The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables. Int. J. Geriatr. Psychiatry 20, 531– 536 10.1002/gps.1317 15920706 · DOI
- García-Alberca J. M. Lara Muñoz J. P. Berthier Torres M. (2010). Neuropsychiatric and behavioral symptomatology in Alzheimer disease. Actas Esp. Psiquiatr. 38, 212– 222 21104466
- Iwata B. A. Volmer T. R. Zarcone J. R. (1993). “The experimental (functional) analysis of behavioral disorders: methodology, application, and limitations,” in Perspectives on the Use of Nonaversive and Aversive Interventions for Persons with Developmental Disabilities, eds Repp A. C. Singh N. N. (Sycamore, IL: Sycamore Press), 301– 330
- Mukaetova-Ladinska E. B. Harrington C. R. Xuereb J. Roth M. Wischik C. M. (1995). Biochemical, neuropathological, and clinical correlations of neurofibrillary degeneration in Alzheimer’s disease,” in Treating Alzheimer’s and Other Dementias, eds Bergener M. Finkel S. I. (New York: Springer), 57– 80
Cited by
Sorted by citations
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
Dyer, S. M., Harrison, S. L., Laver, K., Whitehead, C., & Crotty, M. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217002344 · Cited by 415
Ueda, T., Suzukamo, Y., Sato, M., & Izumi, S.-I. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.02.003 · Cited by 330
Scales, K., Zimmerman, S. I., & Miller, S. (2017) · The Gerontologist · doi:10.1093/geront/gnx167 · Cited by 297
Feast, A., Moniz-Cook, E., Stoner, C., Charlesworth, G., & Orrell, M. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216000922 · Cited by 290
Chen, Y., Liang, Z., Blanchard, J., Dai, C., Sun, S., Lee, M. H., Grundke, I., Iqbal, K., Liu, F., & Gong, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8375-5 · Cited by 294
The serotonergic system and cognitive function
Štrac, D. Š., Pivac, N., & Mück‐Šeler, D. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0007 · Cited by 282
Coyle, H., Traynor, V., & Solowij, N. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.04.009 · Cited by 274
Leung, D. K. Y., Chan, W. C., Spector, A. E., & Wong, G. H. Y. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5556 · Cited by 282
Sakamoto, M., Ando, H., & Tsutou, A. (2013) · International Psychogeriatrics · doi:10.1017/s1041610212002256 · Cited by 252
Mitrea, L., Nemeș, S. A., Szabo, K., Teleky, B., & Vodnar, D. C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.813204 · Cited by 253
Ismail, Z., Gatchel, J., Bateman, D. R., Barcelos-Ferreira, R., Cantillon, M., Jaeger, J., Donovan, N. J., Mortby, M. E., & Mortby, M. E. (2018) · International Psychogeriatrics · doi:10.1017/s1041610217001880 · Cited by 221
“…emotional dysregulation symptoms are among the most common NPS presenting in mild cognitive impairment (MCI) (Peters et al., 2012), and are, along with other NPS, associated with poorer outcomes overall (Cerejeira et al., 2012) and higher conversion rates from MCI to dementia (Palmer et al., 2007).”
BackgroundKim, B.-K., Noh, G. O., & Kim, K. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02109-w · Cited by 221
Robert, P. H., König, A., Amieva, H., Andrieu, S., Brémond, F., Bullock, R. A., Ceccaldi, M. P., Dubois, B., Gauthier, S. G., Kenigsberg, P.-A., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00054 · Cited by 224
Işık, A. T., Soysal, P., Solmi, M., & Veronese, N. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4965 · Cited by 205
Yunusa, I. U., Alsumali, A., Garba, A. E., Regestein, Q. R., & Eguale, T. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0828 · Cited by 215
Serotonin and emotion, learning and memory
Meneses, A., & Liy-Salmerón, G. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0060 · Cited by 203
Depressive symptoms in neurodegenerative diseases
Baquero, M. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i8.682 · Cited by 187
The Course of Neuropsychiatric Symptoms in Dementia: A 3-Year Longitudinal Study
Brodaty, H., Connors, M. H., Xu, J., Woodward, M., & Ames, D. J. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.12.018 · Cited by 181
Schwertner, E., Pereira, J. B., Xu, H., Sečník, J., Winblad, B. G., Eriksdotter, M., Nägga, K., & Religa, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215198 · Cited by 162
Neuropsychiatric Symptoms in Mild Cognitive Impairment: A Literature Review
Martin, E., & Velayudhan, L. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000507078 · Cited by 163
Recent advances in the neurobiology and neuropharmacology of Alzheimer’s disease
Kumar, K., Kumar, A., Keegan, R. M., & Deshmukh, R. R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.053 · Cited by 159
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
Jellinger, K. A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02449-2 · Cited by 155
Kandiah, N., Ong, P. A., Turana, Y., Ng, L., Mamun, K., Merchant, R. A., Chen, C., Dominguez, J. C., Marasigan, S., Ampil, E. R., et al. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13095 · Cited by 146
Siafarikas, N., Selbæk, G., Fladby, T., Benth, J. Š., Auning, E., & Aarsland, D. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217001879 · Cited by 159
Predictors of Institutionalization in Dementia: A Three Year Longitudinal Study
Brodaty, H., on behalf of the PRIME study group, Connors, M. H., Xu, J., Woodward, M., & Ames, D. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131850 · Cited by 136
Ma, M., Dorstyn, D., Ward, L., & Prentice, S. (2018) · Aging & Mental Health · doi:10.1080/13607863.2017.1370689 · Cited by 133
Mortby, M. E., Ismail, Z., Anstey, K. J., & Mortby, M. E. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217001909 · Cited by 134
Behavioural and Psychological Symptoms of Dementia: Correlates and Impact on Caregiver Distress
Mukherjee, A., Biswas, A., Roy, A., Biswas, S., Gangopadhyay, G., & Das, S. K. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000481568 · Cited by 129
Animal-Assisted Intervention and Dementia: A Systematic Review
Yakimicki, M. L., Edwards, N. E., Richards, E. A., & Beck, A. M. (2018) · Clinical Nursing Research · doi:10.1177/1054773818756987 · Cited by 128
Gut microbes in neurocognitive and mental health disorders
Halverson, T., & Alagiakrishnan, K. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1808239 · Cited by 125
Khan, A., Kalaria, R. N., Corbett, A., & Ballard, C. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654987 · Cited by 130
Serotonergic system, cognition, and BPSD in Alzheimer’s disease
Chakraborty, S., Lennon, J. C., Malkaram, S. A., Zeng, Y., Fisher, D. W., & Dong, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.050 · Cited by 127
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
Wong, K. Y., Roy, J., Fung, M., Heng, B. C., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1125 · Cited by 122
Jeon, Y., Luscombe, G. M., Chenoweth, L., Stein‐Parbury, J., Brodaty, H., King, M. T., & Haas, M. R. (2011) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2011.10.020 · Cited by 120
Borges-Machado, F., Barros, D., Ribeiro, Ó., & Carvalho, J. (2020) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317520976720 · Cited by 116
Sensory stimulation for persons with dementia: a review of the literature
Strøm, B. S., Ytrehus, S., & Grov, E. K. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13169 · Cited by 118
Guidelines for pharmacotherapy in Alzheimer’s disease – A primer on FDA-approved drugs
Varadharajan, A., Davis, A. D., Ghosh, A., Jagtap, T., Xavier, A., Menon, A. J., Roy, D., Gandhi, S., & Gregor, T. (2023) · Journal of Neurosciences in Rural Practice · doi:10.25259/jnrp_356_2023 · Cited by 123
Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem
Parsons, C. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098616670798 · Cited by 113
The Use of Music Playlists for People with Dementia: A Critical Synthesis
Garrido, S., Dunne, L., Chang, E. M. L., Perz, J., Stevens, C., & Haertsch, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170612 · Cited by 111
Lejri, I., Agapouda, A., Grimm, A., & Eckert, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9695412 · Cited by 109
Present Algorithms and Future Treatments for Alzheimer’s Disease
Grossberg, G. T., Tong, G., Burke, A. D., & Tariot, P. N. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180903 · Cited by 111
Kwon, C., & Lee, B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.741059 · Cited by 111
da Costa, A. L. C., Bak, T. H., Caffarra, P., Caltagirone, C., Ceccaldi, M. P., Collette, F., Crutch, S. J., Sala, S. D., Démonet, J., Dubois, B., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0254-x · Cited by 114
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
Kumar, S., Chowdhury, S., & Kumar, S. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0394-8 · Cited by 103
Ikarashi, Y., & Mizoguchi, K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.018 · Cited by 103
Setoguchi, S., Wang, P. S., Brookhart, M. A., Canning, C. F., Kaci, L., & Schneeweiß, S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01839.x · Cited by 100
Chronic Stress, Social Isolation, and Perceived Loneliness in Dementia Caregivers
Kovaleva, M. A., Spangler, S. A., Clevenger, C. K., & Hepburn, K. W. (2018) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20180329-04 · Cited by 104
Werner, J., Wosch, T., & Gold, C. (2015) · Aging & Mental Health · doi:10.1080/13607863.2015.1093599 · Cited by 97
Sheykhhasan, M., Amini, R., Asl, S. S., Saidijam, M., Hashemi, S. M., & Najafi, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113224 · Cited by 105
Effects of Music on Agitation in Dementia: A Meta-Analysis
Pedersen, S. K. A., Andersen, P. N., Lugo, R. G., Andreassen, M., & Sütterlin, S. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.00742 · Cited by 119
Eissa, N., Sadeq, A. S., Sasse, A., & Sadek, B. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00886 · Cited by 99
Behavioral symptoms related to cognitive impairment
Dillon, C., Serrano, Castro, Heisecke, S. L., Taragano, & Leguizamon, P. P. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s47133 · Cited by 104
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Dekens, D. W., Eisel, U. L. M., Gouweleeuw, L., Schoemaker, R. G., Deyn, P. P. D., & Naudé, P. J. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101414 · Cited by 93
Das, S., Pal, S., & Ghosal, M. K. (2012) · Neurology India · doi:10.4103/0028-3886.105197 · Cited by 91
Moyle, W., Jones, C., Murfield, J., Thalib, L., Beattie, E., Shum, D., O’Dwyer, S., Mervin, M. C., & Draper, B. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.01.007 · Cited by 90
Detecting agitation and aggression in people with dementia using sensors—A systematic review
Khan, S. S., Ye, B., Taati, B., & Mihailidis, A. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.004 · Cited by 94
Anxiety and Stigma in Dementia
Riley, R. J., Burgener, S. C., & Buckwalter, K. C. (2014) · Nursing Clinics of North America · doi:10.1016/j.cnur.2014.02.008 · Cited by 84
Pharmaceutical Treatment for Alzheimer’s Disease and Related Dementias: Utilization and Disparities
Barthold, D., Joyce, G., Ferido, P., Drabo, E. F., Marcum, Z. A., Gray, S. L., & Zissimopoulos, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200133 · Cited by 85
Souza, L. C., Jessé, C. R., Antunes, M. S., Ruff, J. R., Janner, D. E., Gomes, N. S., Donato, F., Giacomeli, R., & Boeira, S. P. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.002 · Cited by 83
TGF-β Signaling: A Therapeutic Target to Reinstate Regenerative Plasticity in Vascular Dementia?
Kandasamy, M., Anusuyadevi, M., Aigner, K. M., Unger, M. S., Kniewallner, K. M., Sousa, D. M. B. D., Altendorfer, B., Mrowetz, H., Bogdahn, U., & Aigner, L. (2020) · Aging and disease · doi:10.14336/ad.2020.0222 · Cited by 77
Gold, C., Eickholt, J., Aßmus, J., Stige, B., Wake, J. D., Baker, F. A., Tamplin, J., Clark, I. N., Lee, Y.-E. C., Jacobsen, S. L., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023436 · Cited by 83
Genetic Markers of Alzheimer’s Disease
Perković, M. N., & Pivac, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_3 · Cited by 82
Hjetland, G. J., Pallesen, S., Thun, E., Kolberg, E., Nordhus, I. H., & Flo, E. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101310 · Cited by 74
Music and Dementia: Individual Differences in Response to Personalized Playlists
Garrido, S., Stevens, C., Chang, E. M. L., Dunne, L., & Perz, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180084 · Cited by 78
Factors associated with sleep in family caregivers of individuals with dementia
Peng, H., Lorenz, R. A., & Chang, Y. (2018) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12307 · Cited by 75
Guzman-Parra, J., Barnestein-Fonseca, P., Guerrero-Pertiñez, G., Anderberg, P., Jimenez-Fernandez, L., Valero-Moreno, E., Goodman-Casanova, J. M., Cuesta-Vargas, A., Garolera, M., Quintana, M., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/17253 · Cited by 69
Mortby, M. E., Burns, R. A., Eramudugolla, R., Ismail, Z., & Anstey, K. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170050 · Cited by 77
Saragih, I. D., Tonapa, S. I., Saragih, I. S., & Lee, B.-O. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2022.104181 · Cited by 65
Finney, G. R., Minagar, A., & Heilman, K. M. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.08.001 · Cited by 72
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease
Cohen, S., Cummings, J. L., Knox, S., Potashman, M. H., & Harrison, J. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.41 · Cited by 71
Heath, C. J., Bussey, T. J., & Saksida, L. M. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4009-8 · Cited by 71
Khoo, S. A., Chen, T. Y., Ang, Y. H., & Yap, P. L. K. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213001518 · Cited by 74
Liu, X., Chen, W., Hou, H., Chen, X., Zhang, J., Liu, J., Guo, Z., & Bai, G. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.037 · Cited by 69
Impact of behavioral and psychological symptoms of Alzheimer’s disease on caregiver outcomes
Pinyopornpanish, K., Soontornpun, A., Wongpakaran, T., Wongpakaran, N., Tanprawate, S., Pinyopornpanish, K., Nadsasarn, A., & Pinyopornpanish, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-18470-8 · Cited by 70
Neuropsychiatric symptoms in dementia may predict caregiver burden: a Sicilian exploratory study
Torrisi, M., Cola, M. C. D., Marra, A., Luca, R. D., Bramanti, P., & Calabrò, R. S. (2016) · Psychogeriatrics · doi:10.1111/psyg.12197 · Cited by 69
Supporting Family Caregivers With Technology for Dementia Home Care: A Randomized Controlled Trial
Williams, K. N., Perkhounkova, Y., Shaw, C. A., Hein, M., Vidoni, E. D., & Coleman, C. (2019) · Innovation in Aging · doi:10.1093/geroni/igz037 · Cited by 71
Shim, M., Tilley, J. L., Im, S., Price, K., & Gonzalez, A. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720957104 · Cited by 70
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Londzin, P., Zamora, M., Kąkol, B., Taborek, A., & Folwarczna, J. (2021) · Nutrients · doi:10.3390/nu13020537 · Cited by 71
Gustafsson, M. V., Karlsson, S., & Lövheim, H. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-10 · Cited by 70
Induction of embryogenic competence in somatic plant cells: a review
Fehér, A., Pasternak, T. P., Ötvös, K., Miskolczi, P., & Dudits, D. (2002) · Cited by 67
de Oliveira, A. M., Radanovic, M., Homem de Mello, P. C., Buchain, P. C., Dias Vizzotto, A., Harder, J., Stella, F., Piersol, C. V., Gitlin, L. N., & Forlenza, O. V. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4958 · Cited by 67
Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer’s Disease
Wolinsky, D., Drake, K., & Bostwick, J. R. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0978-8 · Cited by 73
Calabrese, J. R., D, M. F. M., Garibaldi, G. M., Grunze, H., Krystal, A. D., LAUGHREN, T. P., Macfadden, W., Marin, R. S., Nierenberg, A. A., & Tohen, M. F. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.056 · Cited by 72
Burdea, G., Polistico, K., Krishnamoorthy, A., House, G., Rethage, D., Hundal, J. S., Damiani, F., & Pollack, S. Z. (2014) · Disability and Rehabilitation Assistive Technology · doi:10.3109/17483107.2014.900575 · Cited by 66
Ballarini, T., Iaccarino, L., Magnani, G., Ayakta, N., Miller, B. L., Jagust, W. J., Gorno‐Tempini, M., Rabinovici, G. D., & Perani, D. (2016) · Human Brain Mapping · doi:10.1002/hbm.23305 · Cited by 65
Bränsvik, V., Granvik, E., Minthon, L., Nordström, P., & Nägga, K. (2020) · Aging & Mental Health · doi:10.1080/13607863.2020.1727848 · Cited by 66
Hindam, M. O., Sayed, R. H., Skalicka‐Woźniak, K., Budzyńska, B., & Sayed, N. S. E. (2020) · Phytotherapy Research · doi:10.1002/ptr.6686 · Cited by 68
Wearables measuring electrodermal activity to assess perceived stress in care: a scoping review
Klimek, A., Mannheim, I., Schouten, G., Wouters, E., & Peeters, M. W. H. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.19 · Cited by 74
Brain Region-Specific Monoaminergic Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease
Vermeiren, Y., Dam, D. V., Aerts, T., Engelborghs, S., & Deyn, P. P. D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140309 · Cited by 68
Knowledge of Dementia Among the Australian Health Workforce: A National Online Survey
Annear, M. J. (2020) · Journal of Applied Gerontology · doi:10.1177/0733464817752085 · Cited by 64
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 72
Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias
Balázs, N., Bereczki, D., & Kovács, T. (2021) · Ideggyógyászati Szemle · doi:10.18071/isz.74.0379 · Cited by 65
Chen, R., Liu, C., Lin, M., Peng, L., Chen, L., Liu, L., & Chen, L. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12126 · Cited by 62
Wu, J., Wang, Y., & Wang, Z. (2017) · Journal of Advanced Nursing · doi:10.1111/jan.13311 · Cited by 62
Moyle, W., Murfield, J., Jones, C., Beattie, E., Draper, B., & Ownsworth, T. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1498447 · Cited by 66
Altomari, N., Bruno, F., Laganà, V., Smirne, N., Colao, R., Curcio, S., Lorenzo, R. D., Frangipane, F., Maletta, R., Puccio, G., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215061 · Cited by 67
Marcinkowska, M., Śniecikowska, J., Fajkis-Zajączkowska, N., Paśko, P., Franczyk, W., & Kołaczkowski, M. (2020) · CNS Drugs · doi:10.1007/s40263-020-00707-7 · Cited by 65
Neuropsychiatric symptoms in dementia—A role for neuroinflammation?
Holmgren, S., Hjorth, E., Schultzberg, M., Lärksäter, M., Frenkel, D., Tysen-Bäckström, A. C., Aarsland, D., & Freund‐Levi, Y. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.09.003 · Cited by 62
Metadata
- Authors
- Cerejeira, J., Lagarto, L., & Mukaetova-Ladinska, E. B.
- Affiliations
- Unidade Local de Saúde de Coimbra (PT)
- ORCID
- Cerejeira, J.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 73-73
- ISSN
- 1664-2295 (ISSN-L)
- PMC
- PMC3345875
- OpenAlex
- W2120296399
- Cited by
- 1,425
- References
- 214
- Citations by year
- 2026: 111 · 2025: 138 · 2024: 144 · 2023: 188 · 2022: 129 · 2021: 150 · 2020: 122 · 2019: 92 · 2018: 90 · 2017: 78 · 2016: 59 · 2015: 38 · 2014: 32 · 2013: 27 · 2012: 13
- FWCI
- 25.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Frontiers in Neurology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- behavioral and psychological symptoms of dementia, neuropsychiatric symptoms, dementia, agitation, anxiety, depression, apathy, delusions, hallucinations, sleep disorders, non-pharmacological treatment, pharmacotherapy, pathogenesis, genetic factors, neuropathology, caregiver burden
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review